申请人:Goldstein Solo
公开号:US20050032845A1
公开(公告)日:2005-02-10
A compound selected from those of formula (1):
wherein: p represents an integer of from 0 to 6 inclusive, n represents an integer of from 0 to 6 inclusive,
R
1
, and R
2
represent a group selected from hydrogen, alkyl, aryl and arylalkyl, or R
1
+R
2
form together with nitrogen carrying them saturated, monocyclic, or bicyclic system,
X represents a group selected from oxygen, sulphur, a group —CH═CH—, methylene, a group of formula —HC═N—O— and a group of formula —O—CH
2
—CH═CH—, in which groups oxygen is linked to Y of the compounds of formula (I), Y represents a group selected from aryl, heteroaryl, arylalkyl, heteroarylalkyl, —C(O)-A, and —C(S)-A,
A represents a group selected from alkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and NR
3
R
4
wherein R
3
, and R
4
represent a group selected from hydrogen, alkyl, aryl, and arylalkyl, or R
3
+R
4
form together with nitrogen carrying them monocyclic, or bicyclic (C
3
-C
10
) system,
its isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific nicotinic ligand of α
4
β
2
receptors.
从式(1)中选择的化合物:其中:p表示0至6的整数,n表示0至6的整数,R1和R2表示从氢,烷基,芳基和芳基烷基中选择的基团,或R1 + R2形成饱和的氮,单环或双环系统,X表示从氧,硫,-CH═CH-,亚甲基,式- HC═N-O-和式-O-CH2-CH═CH-中选择的基团,在这些基团中氧与式(I)中化合物的Y连接,Y表示从芳基,杂环芳基,芳基烷基,杂环芳基烷基,-C(O)-A和-C(S)-A中选择的基团,A表示从烷基,芳基,杂环芳基,芳基烷基,杂环芳基烷基和NR3R4中选择的基团,其中R3和R4表示从氢,烷基,芳基和芳基烷基中选择的基团,或R3 + R4形成单环或双环(C3-C10)系统,其异构体和与药物可接受的酸或碱的加合物,以及含有它们的药物制剂,作为α4β2受体的特异性烟碱性配体是有用的。